Posts

AstraZeneca Cancels £450 Million UK Vaccine Plant Expansion Amid Government Funding Reduction

on

FDA Approves Axsome's Symbravo for Rapid Migraine Relief

on

Metsera and Maze Therapeutics Raise $415 Million in Successful Biotech IPOs

on

Sanofi's Beyfortus Achieves Blockbuster Status, Poised for Further Growth in US Market

on

Cargo Therapeutics Discontinues Lead CAR-T Program Due to Poor Durability and Safety Concerns

on

Metsera Raises $275M in IPO to Advance GLP-1 Weight Loss Drug to Phase 3

on

Abbott's Spinal Cord Stimulation Systems Demonstrate Long-Term Efficacy in Chronic Pain Management

on

Inhibikase Halts Parkinson's Drug Development After Phase II Failure, Shifts Focus to Pulmonary Arterial Hypertension

on

Merck Halts HYPERION Trial of Winrevair Early Due to Overwhelming Efficacy in PAH Treatment

on

New year starts with a bang as trio of venture financings brings in $382M

on

FDA Approves Monthly Maintenance Dosing for Eisai and Biogen's Alzheimer's Drug Leqembi

on

Roche's Itovebi Demonstrates Significant Overall Survival Benefit in Advanced Breast Cancer Study

on

Rentschler Biopharma Exits Cell and Gene Therapy Sector, Refocuses on Biologics Manufacturing

on

Sage Therapeutics Rejects Biogen's Acquisition Bid, Initiates Strategic Review

on

Dual Hormone Therapies Normalize Sleep Patterns in ALS Mouse Models

on

Senate Grills RFK Jr. on Controversial Health Stances in Contentious HHS Secretary Confirmation Hearings

on

Julie Kim to Succeed Christophe Weber as Takeda's CEO in 2026

on

Secretary Rubio Expands Humanitarian Exemptions in US Foreign Aid Freeze

on

Senate Hearing for RFK Jr. Amid Strong Public Support for Vaccine Access

on

Zentalis Pharmaceuticals Cuts Workforce by 40% to Advance WEE1 Inhibitor to Registrational Trial

on

FDA Postpones Opioids Advisory Committee Meeting and Cancels Kidney Drug Review

on

Delaware Court Ruling Paves Way for Aurion Biotech IPO, Alcon to Appeal Decision

on

FDA Approves Ozempic for Reducing Kidney Disease Risks in Adults with Type 2 Diabetes and Chronic Kidney Disease

on

ITM's Radiopharmaceutical ITM-11 Shows Promising Results in Phase III COMPOSE Trial for Advanced Neuroendocrine Tumors

on

Amgen and Celltrion Reach Settlement in Denosumab Patent Litigation, Paving Way for Mid-2025 Biosimilar Launch

on

Leap Therapeutics' Stock Plummets Following Disappointing DKK1 Antibody Results in Gastric Cancer Trials

on

Trump 2.0: RFK Confirmation Hearings and Ongoing Clinical Trials Amidst Administrative Changes

on

Allakos Announces Discontinuation of AK006 Program and 75% Layoffs Following Clinical Trial Failures

on

Sarepta Therapeutics Reports Encouraging Two-Year Data for ELEVIDYS in Duchenne Muscular Dystrophy, Projecting $1 Billion in Sales

on

Retro Biosciences, Backed by Sam Altman, Seeks $1 Billion to Extend Human Lifespan by 10 Years

on

Enhertu Secures 7th FDA Approval for Expanded Use in HER2-Low and HER2-Ultralow Breast Cancer

on

FDA Names Dr. Sara Brenner as Acting Commissioner

on

Akero Therapeutics Stock Skyrockets as Phase 2b MASH Trial Yields Groundbreaking Results

on

Kailera Therapeutics Appoints Jamie Coleman as Chief Commercial Officer

on

Sage Therapeutics Rejects Biogen's Acquisition Proposal, Remains Open to Future Deals

on

Aurion Biotech Presses On with IPO Plans Amid Legal Dispute with Investor Alcon

on

Breaking the Silence: Endo's "I Got Somebody" Campaign Encourages Men to Seek Help for Peyronie's Disease

on

Vigil Neuroscience's Oral Alzheimer's Candidate VG-3927 Shows Promising Phase 1 Results with Sanofi's Strategic Support

on

Neomorph Secures Third Major Collaboration with AbbVie for Molecular Glue Degraders Worth Up to $1.64 Billion

on